Abstract:Current guidelines recommend screening for PA in patients with hypertension on the basis of individual factors, that considered together are present in more than 50% of patients. Recently, some experts proposed to further expand the screening for PA to all patients with hypertension, potentially increasing the burden and the costs on the health care system. We designed a study to build and validate prediction models based on supervised learning and a conventional scoring system to define the risk of PA in arterial hypertension and tailor the diagnostic workup to the individual risk of each patient. We developed a clinical score and supervised machine learning algorithms in a retrospective internal cohort of 4059 patients with hypertension, and an external cohort of 584 patients with hypertension. Primary aldosteronism was confirmed by confirmatory tests, in agreement with major international recommendations, and subtype diagnosis was achieved by computed tomography and adrenal vein sampling. On the basis of 6 widely available parameters (male sex, systolic blood pressure, antihypertensive treatment, body mass index, lowest potassium, and organ damage) we developed a numerical scoring system (SToP-PA score) and 308 machine learning based models, selecting the one with the highest predicting performances. At internal validation we obtained high predictive performance with SToP-PA score (ptimised sensitivity of 90.7% for PA and 92.3% for unilateral PA) and even higher with machine learning based model (ptimised sensitivity of 96.6% for PA, and 100.0% for unilateral PA). The application of these models allowed the identification of a subgroup of patients with very low probability of having PA (0.6% with both models) and null probability of having unilateral PA. Finally, we validated our models within an independent external cohort, with performance not significantly different from internal validation. The SToP-PA score and the machine learning model accurately predict the individual pretest probability of PA in patients with hypertension, avoiding the screening for PA in up to 32.7% of patients using a machine learning algorithm, without omitting patients with unilateral UPA.

"Clinical prediction model for masked hypertension diagnosed by 24-h ambulatory blood pressure measurements in a sample from specialized hospital."

Utility of 24-hour ambulatory blood pressure monitoring for detecting masked hypertension and masked uncontrolled hypertension

Twenty-Four-Hour Ambulatory Blood Pressure Monitoring

Machine Learning–Based Prediction of Masked Hypertension Among Children With Chronic Kidney Disease

Prediction of Masked Hypertension and Masked Uncontrolled Hypertension Using Machine Learning

Predictive Models for Sustained, Uncontrolled Hypertension and Hypertensive Crisis Based on Electronic Health Record Data: Algorithm Development and Validation

Strategies for Classifying Patients Based on Office, Home, and Ambulatory Blood Pressure Measurement

Ambulatory Blood Pressure Monitoring to Diagnose and Manage Hypertension

[May Measurement Month 2019: Screening Analysis In Spanish Community Pharmacies and Detection of Masked Hypertension]

DEVELOPMENT OF CLINICAL SCORING SYSTEM AND MACHINE LEARNING-BASED MODEL TO PREDICT DIAGNOSIS OF PRIMARY ALDOSTERONISM IN PATIENTS WITH HYPERTENSION

Response to: Correspondence on 'Utility of 24-hour ambulatory blood pressure monitoring for detecting masked hypertension and masked uncontrolled hypertension' by Espeche et al.

Artificial Intelligence–Derived Risk Prediction: A Novel Risk Calculator Using Office and Ambulatory Blood Pressure

Accuracy of Home Versus Ambulatory Blood Pressure Monitoring in the Diagnosis of White-Coat and Masked Hypertension

Masked hypertension is “unmasked” by low-intensity exercise blood pressure

P075 IS OFFICE BLOOD PRESSURE MEASUREMENT SUFFICIENT FOR DIAGNOSING HYPERTENSION IN PRIMARY HEALTH CARE?

AMBULATORY AND HOME BLOOD PRESSURE MONITORING FOR CARDIOVASCULAR DISEASE RISK EVALUATION: A SYSTEMATIC REVIEW AND META-ANALYSIS OF PROSPECTIVE COHORT STUDIES

Masked hypertension incidence and risk factors in a prospective cohort study

Unattended automatic blood pressure measurements versus conventional office readings in predicting hypertension-mediated organ damage

Economic Impact of Ambulatory Blood Pressure Monitoring Compared With Clinical Blood Pressure Monitoring: A Simulation Model

A0241 Use of Ambulatory Blood Pressure Monitoring in the Diagnosis of White Coat and Masked Hypertension

A Comparative Meta-Analysis of Prospective Observational Studies on Masked Hypertension and Masked Uncontrolled Hypertension Defined by Ambulatory and Home Blood Pressure